Inactive Instrument

Highlights bioMérieux Euronext Paris

Equities

BIOMÉRIEUX : Berenberg raises its target	Apr. 26	CF
BIOMÉRIEUX : Stifel raises target price	Apr. 10	CF
BIOMÉRIEUX : Oddo BHF raises its target price	Apr. 10	CF
BIOMÉRIEUX : Invest Securities raises its target	Apr. 10	CF
BIOMERIEUX : A strong start to 2024	Apr. 09
BioMérieux: hailed for its business review and targets	Apr. 09	CF
BioMérieux: targets set for 2024-28	Apr. 09	CF
BioMérieux: growth of over 6% in Q1	Apr. 09	CF
BioMérieux: food safety initiative	Apr. 05	CF
BIOMERIEUX : Good end to 2023; routine testing dynamics remain intact	Mar. 14
BioMérieux S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
BioMérieux: RNPG down 21% in 2023	Mar. 14	CF
BioMérieux Buys Remaining 84% Stake in Canada's Lumed	Jan. 08	MT
BioMérieux: full acquisition of Lumed	Jan. 08	CF
BioMérieux S.A. acquired remaining 84% stake in Luméd inc.	Jan. 04	CI
BioMerieux Partners with White Labs to Develop GENE-Up® BrewPRO? Yeast Slurry	23-10-24	CI
Oxford Nanopore gets bioMerieux backing as announces clinical foray	23-10-19	AN
BioMérieux Invests GBP70 Million in Oxford Nanopore Technologies	23-10-19	MT
BioMérieux S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31	CI
Ex-dividend day for final dividend	23-06-05	FA

No results for this search

BIOMERIEUX : A strong start to 2024

April 09, 2024 at 10:38 am EDT